** Shares in Norwegian biopharmaceutical firm BIOTEC.OL up
22 pct after co reported on Thursday strong Woulgan results from
300 patient study urn:newsml:reuters.com:*:nWkrjKDf1
** Study shows Woulgan Gel significantly increases
likelihood of wound healing compared to standard care for
stalled wounds of all types
** Shares traded 20 times their 30-day avg
** Stock set for best day and highest price in 4 mths
((joanna.wodzicka.thomsonreuters.com@reuters.net;
jagoda.darlak.thomsonreuters.com@reuters.net))